The Consortium in Action

The 2024 Cannabis Clinical Outcomes Research Conference, or CCORC, put the spotlight on the latest research and health advances in the medical marijuana field — at a time when federal regulators are in the process of reclassifying medical marijuana as a lower-risk substance.

On December 13, 2023, Consortium Director Almut Winterstein, RPh, PhD, FISPE, provided a report on Consortium activity to the Healthcare Regulation Subcommittee of the Florida House of Representatives. The presentation included an overview of the Consortium’s research programs and shared updates on data regarding certified medical marijuana patient demographics, average…

The third annual Cannabis Clinical Outcomes Research Conference took place May 18-19 at the UF Research and Academic Center in Orlando. More than 120 attendees, including faculty and students from the UF College of Pharmacy, shared their latest research findings about cannabis and gained a greater understanding of medical marijuana use on…

On February 15, 2023, Consortium Director Almut Winterstein, RPh, PhD, FISPE provided a report on Consortium activity to the Healthcare Regulation Subcommittee of the FL House of Representatives. This presentation included an overview of the Consortium’s history and research program, 2022-2023 research highlights, and key initiatives for 2023-2024. An archived…

Medical marijuana researchers, clinicians, policymakers and trainees gathered in Orlando on May 19-20 for the second annual Cannabis Clinical Outcomes Research Conference. The event attracted more than 100 participants to discuss the ever-changing landscape of medical marijuana research in Florida and beyond.

Listen to the Consortium Director, Dr. Almut Winterstein, to introduce the Consortium and its research program.

Lack of cannabis use assessments contributes to under-documenting use, limited research, and more Evidence on the safety and effectiveness of medical marijuana lacks behind the increase in cannabis use for a variety of medical conditions. One source of data to elucidate our understanding of cannabis effects are real-world data such…

On November 3, 2021, Consortium Director Almut Winterstein, RPh, PhD, FISPE provided a report on Consortium activity to the Professions and Public Health Subcommittee of the FL House of Representatives. This presentation included an overview of the Consortium’s history and research program, research highlights, and strategic goals. An archived recording…

Pilot study investigates effects of medical cannabis on pain, anxiety, depression, sleep Based on a small-scale, non-controlled pilot study led by Yan Wang, PhD at the University of Florida, medical cannabis may have the potential to reduce pain intensity, anxiety, and depression and may improve sleep and quality of life….

Ruba Sajdeya, MD awarded the 2021 AHSR Early Career Investigator Award Ruba Sajdeya, MDConsortium Graduate Student Ruba Sajdeya, MD, a research assistant in the Consortium and graduate student received the 2021 Addiction Health Services Research Conference (AHSR) Early Career Investigator Award for her abstract poster submission, “Free-text searching algorithms to…

Review of Cannabis Pharmacology, Uses, Adverse Drug Events, and Drug Interactions In a recent review led by Joshua Brown, PharmD, PhD, researchers at the University of Florida describe the current environment for natural and synthetic cannabinoid use.  Published in The Journal of Clinical Pharmacology, the review provides context for the chemistry…

Physicians indicate their clinical practices rely on a blend of research and anecdotal information Between June and October 2020, the Consortium conducted a cross-sectional state-wide survey of registered medical marijuana physicians in Florida. The survey aimed to understand training needs, prescribing practices, and desired research priorities. Led by Consortium member,…

Consortium Members present at the Research Society on Marijuana Consortium members presented their research at the 5th Annual Meeting of the Research Society on Marijuana (RsMJ) on July 23, 2021. The Research Society on Marijuana (RSMj) is a network of scientists with the goal to promote understanding through research of the consequences…

What about a Standardized Cannabis Unit? One of the largest challenges for cannabis research is the standardization of cannabis dose. In this article of Evidence in Context: Much Ado about Dosing, the Consortium assesses the needs and challenges of defining a standardized cannabis unit. Needs and barriers for the implementation…

Cannabis Clinical Outcomes Research Conference (CCORC) 2021 attracts more than 225 participants across the world On Thursday, April 8th and Friday, April 9th, 2021, the Consortium for Medical Marijuana Clinical Outcomes Research hosted its inaugural research conference, Cannabis Clinical Outcomes Research Conference (CCORC). In response to the COVID-19 pandemic, the…

3-7% of Pregnant Women in the USA Report Using MMJ During Pregnancy Since the early 2000s, cannabis use during pregnancy has doubled. The Substance Abuse and Mental Health Services Administration found that 3-7% of pregnant women in the USA reported medical marijuana use during pregnancy, specifically for nausea and vomiting…

Mask Up for the Health of It: Gainesville Health & Wellness Fair On Saturday, April 10, 2021, the Consortium for Medical Marijuana Clinical Outcomes Research Consortium attended the 4th Annual Gainesville Health & Wellness Fair hosted at the University of Florida HealthStreet. Open to Gainesville and Alachua County communities, the…

Understanding Medical Marijuana and its Potential Benefits and Harms in Older Adults Living with Pain On Tuesday, February 23, 2021, Dr. Robert Cook and Dr. Yan Wang presented for the Integrative Pain Management Series for Health Care Providers on medical marijuana and its effects on chronic pain and related health outcomes. The…

Evidence on Medical Marijuana Safety and Effectiveness: Read with Caution The Consortium leads for evidence and for MEMORY, Dr. Amie Goodin and Dr. Joshua Brown, published a commentary on the rigor of studies evaluating the safety and effectiveness of medical marijuana in the Consortium’s Evidence in Context Series: High Risk…

Consortium Launches “Evidence in Context” Commentary Series Joshua Brown, PharmD, PhD, MSConsortium Faculty Lead – MEMORY Amie Goodin, PhD, MPPConsortium Faculty Lead – Evidence Evidence for medical cannabis and cannabinoids continues to evolve rapidly while researchers, healthcare providers, and patient communities remain in need of clear translation of study findings…

On July 24th, Consortium team members, Ruba Sajdeya, MD, and Sebastian Jugl, BPharm, RPh, presented posters virtually at the 4th annual scientific meeting of Research Society on Marijuana (RSMj).

As part of the UF Health Palliative Care’s Cancer Educational Wellness Series, Dr. Robert L. Cook, Consortium Associate Director, presented “Medical Marijuana as a Treatment for Cancer and Cancer-Related Symptoms” on July 22nd.

On March 11th, 2020, Dr. Almut Winterstein, Consortium Director; Dr. Robert L. Cook, Consortium Associate Director; and Dr. Amie Goodin, Consortium Faculty Lead – Research Strategy, presented at the University of Florida EyeOpener Discovery Breakfast.

As part of the outreach activities of the Consortium, Dr. Robert L. Cook, Consortium Associate Director, and Dr. Yan Wang, Consortium Faculty Lead – Clinical Core, presented at the Research and Medical Cannabinoids CME in Ocala on February 29th, 2020.

Members of the Consortium for Medical Marijuana Clinical Outcomes Research Team attended and hosted an exhibit at the American Medical Marijuana Physicians Association (AMMPA) Annual Conference in Orlando, FL from October 4 through October 6, 2019.